Țară: Regatul Unit
Limbă: engleză
Sursă: MHRA (Medicines & Healthcare Products Regulatory Agency)
Propylthiouracil
DE Pharmaceuticals
H03BA02
Propylthiouracil
50mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 06020200
PACKAGE LEAFLET INFORMATION FOR THE USER PROPYLTHIOURACIL 50MG TABLETS (PROPYLTHIOURACIL) READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE. − Keep this leaflet. You may need to read it again. − If you have any further questions, please ask your doctor or pharmacist. − This medicine has been prescribed for you personally and you should not pass it on to others. It may harm them, even if their symptoms are the same as yours. The name of your medicine is Propylthiouracil 50mg Tablets. In the rest of this leaflet it is called Propylthiouracil Tablets. IN THIS LEAFLET: 1. WHAT PROPYLTHIOURACIL TABLETS ARE AND WHAT THEY ARE USED FOR 2. BEFORE YOU TAKE PROPYLTHIOURACIL TABLETS 3. HOW TO TAKE PROPYLTHIOURACIL TABLETS 4. POSSIBLE SIDE EFFECTS 5. HOW TO STORE PROPYLTHIOURACIL TABLETS 6. FURTHER INFORMATION 1. WHAT PROPYLTHIOURACIL TABLETS ARE AND WHAT THEY ARE USED FOR The active ingredient in Propylthiouracil Tablets is propylthiouracil, which belongs to a group of medicines called antithyroid drugs. These medicines work by reducing the production of a hormone called thyroxine by the thyroid gland (a gland located beneath the box in the throat that produces thyroid hormone and helps to regulate growth and metabolism). Propylthiouracil Tablets are used in the treatment and management of an overactive thyroid gland (hyperthyroidism). 2. BEFORE YOU TAKE PROPYLTHIOURACIL TABLETS DO NOT TAKE PROPYLTHIOURACIL TABLETS IF YOU: • are SEVERELY ALLERGIC TO PROPYLTHIOURACIL OR ANY OF THE OTHER INGREDIENTS OF PROPYLTHIOURACIL TABLETS (see section 6 ‘What Propylthiouracil Tablets contain’ for a full list of ingredients). • have a RARE HEREDITARY CONDITION affecting the way your BODY HANDLES SOME SUGARS If any of the above apply to you, you should not take Propylthiouracil Tablets. PROPYLTHIOURACIL TABLETS ARE NOT RECOMMENDED FOR USE IN CHILDREN UNDER SIX YEARS OF AGE. CHECK WITH YOUR DOCTOR IF ANY OF THE FOLLOWING APPLIES TO YOU: • Some cases of severe liver reactions, including cases with fatal o Citiți documentul complet
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Propylthiouracil 50mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Propylthiouracil 50mg 3 PHARMACEUTICAL FORM White circular biconvex uncoated tablets with “I and II” debossed either side of breakline on one side and plain on other side (Approximate Size: 6.5 mm). The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS 1. Management of hyperthyroidism, including the treatment of Graves’ disease and thyrotoxicosis. 2. Amelioration of hyperthyroidism in preparation for surgical treatment. 3. An adjunct to radioactive iodine therapy. 4. In juvenile hyperthyroidism to delay ablative therapy. 5. To manage thyrotoxic crisis. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Propylthiouracil is administered by the oral route. Adults: Management of Hyperthyroidism The initial dose of propylthiouracil is between 300mg and 600mg given as a single daily dose. This dose should be maintained until the patient becomes euthyroid. The dose should then be reduced gradually to a maintenance dose of between 50mg and 150mg, taken as a single daily dose. Daily doses can be divided if preferred. Preparation for Surgery As for management of hyperthyroidism, until the patient becomes euthyroid. Adjunct to Radioactive Iodine Therapy As for management of hyperthyroidism, for several weeks prior to radioiodine treatment. Withdraw propylthiouracil 2 to 4 days before irradiation. The dosage of radio-iodine may need to be adjusted because propylthiouracil may have a radioprotective effect. Management of Thyrotoxic Crisis 200mg every 4 to 6 hours for the first 24 hours, decrease the dose as the crisis subsides. Elderly The adult dose should apply, but caution is advised in the presence of renal or hepatic impairment, where a dosage reduction may be justified. Children: Juvenile Hyperthyroidism Children aged 6 - 10 years: Initial dose of 50-150mg daily Children over 10 years: Citiți documentul complet